Published in Radiat Res on April 01, 2000
Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiat Res (2001) 1.90
Assessment of low linear energy transfer radiation-induced bystander mutagenesis in a three-dimensional culture model. Cancer Res (2005) 1.11
Bystander effects caused by nonuniform distributions of DNA-incorporated (125)I. Micron (2002) 1.07
A proliferation-dependent bystander effect in primary porcine and human urothelial explants in response to targeted irradiation. Br J Cancer (2003) 1.05
Targeted alpha-therapy: past, present, future? Dalton Trans (2007) 1.01
Biological response to nonuniform distributions of (210)Po in multicellular clusters. Radiat Res (2007) 0.97
When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry. J Nucl Med (2003) 0.95
Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells. J Nucl Med (2004) 0.92
Demonstration of a radiation-induced bystander effect for low dose low LET beta-particles. Radiat Environ Biophys (2007) 0.87
Modeling multicellular response to nonuniform distributions of radioactivity: differences in cellular response to self-dose and cross-dose. Radiat Res (2005) 0.87
Radiation protection by cysteamine against the lethal effects of intracellularly localized Auger electron, alpha- and beta-particle emitting radionuclides. Acta Oncol (2000) 0.82
Challenges and progress in predicting biological responses to incorporated radioactivity. Radiat Prot Dosimetry (2007) 0.79
Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy. Pediatr Blood Cancer (2014) 0.78
Human Health and the Biological Effects of Tritium in Drinking Water: Prudent Policy Through Science - Addressing the ODWAC New Recommendation. Dose Response (2011) 0.75
Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys (1993) 1.63
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.44
Range of radiochemical damage to DNA with decay of iodine-125. Science (1981) 1.42
The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells. Radiat Res (1991) 1.30
Iodine-125, a tracer in cell biology: physical properties and biological aspects. Phys Med Biol (1970) 1.28
Rdiotoxicity of intracellular 67Ga, 125I and 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 1.27
In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles. Lancet (1989) 1.09
Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro. Radiat Res (1998) 1.09
Inactivation of mammalian cells after disintegration of 3H or 125I in cell DNA at -196 degrees C. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 1.06
Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. Radiat Res (1989) 1.05
MIRD Pamphlet No. 15: Radionuclide S values in a revised dosimetric model of the adult head and brain. Medical Internal Radiation Dose. J Nucl Med (1999) 1.05
Induction of sperm head abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation, dose rate, and presence of radioprotectors. Radiat Res (1991) 1.04
Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo. Radiat Res (1990) 1.02
Radioprotective effects of dimethyl sulfoxide in golden hamster embryo cells exposed to gamma rays at 77 K. II. Protection from lethal, chromosomal, and DNA damage. Radiat Res (1990) 1.02
Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. Radiat Res (1994) 1.01
Effect of dimethyl sulfoxide (DMSO) on radiation-induced heteroallelic reversion in diploid yeast. Mutat Res (1976) 1.00
Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks. Radiat Res (1998) 0.98
A comparison of DNA damages produced under conditions of direct and indirect action of radiation. Int J Radiat Biol (1994) 0.95
Sequence-specific DNA breaks produced by triplex-directed decay of iodine-125. Acta Oncol (1996) 0.91
Similar lethal effect in mammalian cells for two radioisotopes of copper with different decay schemes, 64Cu and 67Cu. Int J Radiat Biol (1989) 0.91
The range of high LET effects from 125I decays. Radiat Res (1986) 0.91
DNA strand breakage by 125I-decay in a synthetic oligodeoxynucleotide--1. Fragment distribution and evaluation of DMSO protection effect. Acta Oncol (1996) 0.91
Strand breaks in plasmid DNA following positional changes of Auger-electron-emitting radionuclides. Acta Oncol (1996) 0.91
Biological toxicity of Auger emitters: molecular fragmentation versus electron irradiation. Curr Top Radiat Res Q (1978) 0.91
Letter: Studies on the mechanism of chemical radioprotection by dimethyl sulphoxide. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 0.90
Modification of radiation effect on the eye by topical application of dimethyl sulfoxide. Radiat Res (1970) 0.88
Vitamins as radioprotectors in vivo. I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of damage caused by the Auger effect. Radiat Res (1994) 0.88
Radioprotection by DMSO against the biological effects of incorporated radionuclides in vivo--Comparison with other radioprotectors and evidence for indirect action of Auger electrons. Acta Oncol (1996) 0.88
DNA strand breakage by 125I-decay in a synthetic oligodeoxynucleotide--2. Quantitative analysis of fragment distribution. Acta Oncol (1996) 0.88
Efficient mutation induction by 125I and 131I decays in DNA of human cells. Radiat Res (1990) 0.87
Solitons and energy transfer in DNA. Nature (1988) 0.87
Modelling of radiation damage by 125I on a nucleosome. Int J Radiat Biol (1994) 0.85
Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothiouronium bromide hydrobromide (AET). J Nucl Med (1995) 0.85
Low-LET and high-LET radiation action of 125I decays in DNA: effect of cysteamine on micronucleus formation and cell killing. Radiat Res (1995) 0.85
Comparison of strand breaks in plasmid DNA after positional changes of Auger electron-emitting iodine-125. Radiat Res (1999) 0.85
Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival. Radiat Res (1998) 0.83
Tritium radiobiology and relative biological effectiveness. Health Phys (1993) 0.83
Protection of tissue-culture cells against ionizing radiation. II. The activity of hypoxia, dimethyl sulphoxide, dimethyl sulphone, glycerol and cysteamine at room temperature and at -196 degrees C. Int J Radiat Biol (1962) 0.83
Chemical and biological consequences of the radioactive decay of iodine-125 in plasmid DNA. Radiat Res (1985) 0.82
Characterization of hydroxyl radical-induced damage after sparsely and densely ionizing irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.82
Thiazolidine prodrugs of cysteamine and cysteine as radioprotective agents. Radiat Res (1995) 0.81
Cysteamine as a protective agent with high-LET radiations. Radiat Res (1980) 0.80
Chemical and biological consequences of beta-decay. Part 2. Radiat Environ Biophys (1977) 0.77
Autotrophic picoplankton in the tropical ocean. Science (1983) 4.80
Inhibitory Effect of Water on Oxygen Consumption by Plant Materials. Plant Physiol (1960) 3.60
ICRP Publication 116. Conversion coefficients for radiological protection quantities for external radiation exposures. Ann ICRP (2012) 2.59
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med (1999) 2.41
Sugar consumption and cigarette smoking. Lancet (1970) 2.22
Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiat Res (2001) 1.90
Detection of lung cancer in a male industrial population. Br J Prev Soc Med (1967) 1.90
Disease coding by computer. The "fruit machine" method. Br J Prev Soc Med (1968) 1.82
Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radiat Res (1999) 1.62
Smoking habits and laboratory tests. Lancet (1970) 1.59
Automatic disease coding: the 'fruit-machine' method in general practice. Br J Prev Soc Med (1973) 1.57
Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions. J Nucl Med (2000) 1.55
Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides. J Nucl Med (1993) 1.53
Relative biological effectiveness of alpha-particle emitters in vivo at low doses. Radiat Res (1994) 1.53
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.44
Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys (1985) 1.44
The impact of recirculating industrial air on aircraft painting operations. Appl Occup Environ Hyg (1999) 1.40
Lung cancer prognosis and routine radiography. Br J Prev Soc Med (1968) 1.38
The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells. Radiat Res (1991) 1.30
Variability in audiometric recording. Br J Ind Med (1972) 1.29
Further evaluation of the Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry (1970) 1.28
A new rectal model for dosimetry applications. J Nucl Med (1999) 1.23
Phosphorus Tolerance and Sensitivity of Soybeans as Related to Uptake and Translocation. Plant Physiol (1964) 1.22
Health workers in the United Kingdom Atomic Energy Authority. Health Phys (1970) 1.18
Response functions for computing absorbed dose to skeletal tissues from photon irradiation. Radiat Prot Dosimetry (2008) 1.16
Tissue-equivalent materials for construction of tomographic dosimetry phantoms in pediatric radiology. Med Phys (2003) 1.14
Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors. Med Phys (1989) 1.11
Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med (1994) 1.10
In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles. Lancet (1989) 1.09
Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med (1994) 1.09
Dietary sugar and ischaemic heart disease. Br Med J (1969) 1.09
Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro. Radiat Res (1998) 1.09
NMR microscopy of trabecular bone and its role in skeletal dosimetry. Health Phys (1998) 1.08
MIRD Pamphlet No. 15: Radionuclide S values in a revised dosimetric model of the adult head and brain. Medical Internal Radiation Dose. J Nucl Med (1999) 1.05
Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides. J Nucl Med (1994) 1.04
Induction of sperm head abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation, dose rate, and presence of radioprotectors. Radiat Res (1991) 1.04
The MIRD perspective 1999. Medical Internal Radiation Dose Committee. J Nucl Med (1999) 1.03
Individual variations in mucosa and total wall thickness in the stomach and rectum assessed via endoscopic ultrasound. Physiol Meas (2003) 1.02
Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo. Radiat Res (1990) 1.02
New cladiellane diterpenes from the soft coral Cladiella australis of the Andaman and Nicobar Islands. J Nat Prod (1994) 1.01
Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. Radiat Res (1994) 1.01
Marching cube algorithm: review and trilinear interpolation adaptation for image-based dosimetric models. Comput Med Imaging Graph (2003) 1.00
Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys (1994) 1.00
Subject variability in short-term audiometric recording. Br J Ind Med (1973) 0.98
Creation of two tomographic voxel models of paediatric patients in the first year of life. Phys Med Biol (2002) 0.98
Inhaled ozone as a mutagen. I. Chromosome aberrations induced in Chinese hamster lymphocytes. Environ Res (1971) 0.97
Vitamin C as a radioprotector against iodine-131 in vivo. J Nucl Med (1993) 0.96
Voxel-based models representing the male and female ICRP reference adult--the skeleton. Radiat Prot Dosimetry (2007) 0.96
Sugar and ischemic heart disease. Br Med J (1969) 0.95
A seven-year review of measured hearing levels in male manual steelworkers with high initial thresholds. Br J Ind Med (1978) 0.95
Simple isolation of polonium-210 from silver. Appl Radiat Isot (1994) 0.94
[125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistribution. J Med Chem (1996) 0.94
Five pediatric head and brain mathematical models for use in internal dosimetry. J Nucl Med (1999) 0.94
Height, weight and obesity in an industrial population. Trans Assoc Ind Med Off (1965) 0.93
Social class and biological tests. Lancet (1970) 0.93
Sickness absence levels and personality inventory scores. Br J Ind Med (1971) 0.93
Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl Med (1988) 0.92
Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. J Nucl Med (1992) 0.91
S values for radionuclides localized within the skeleton. J Nucl Med (2000) 0.90
Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo. Radiat Res (1997) 0.90
Crystalline principles from the leaves and twigs of Leptadenia reticulata. Planta Med (1975) 0.90
Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med (1983) 0.89
Design and performance characteristics of an experimental cesium-137 irradiator to simulate internal radionuclide dose rate patterns. J Nucl Med (1997) 0.89
Improvement of internal dose calculations using mathematical models of different adult heights. Phys Med Biol (2000) 0.89
Obesity and smoking habits. Br Med J (1971) 0.88
Vitamins as radioprotectors in vivo. I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of damage caused by the Auger effect. Radiat Res (1994) 0.88
Radioprotection by DMSO against the biological effects of incorporated radionuclides in vivo--Comparison with other radioprotectors and evidence for indirect action of Auger electrons. Acta Oncol (1996) 0.88
Bystander responses in three-dimensional cultures containing radiolabelled and unlabelled human cells. Radiat Prot Dosimetry (2006) 0.88
Comparative cost analysis of hemilaryngectomy and irradiation for early glottic carcinoma. Int J Radiat Oncol Biol Phys (1983) 0.87
Generalized approach to absorbed dose calculations for dynamic tumor and organ masses. J Nucl Med (1995) 0.87
Biological effect of lead-212 localized in the nucleus of mammalian cells: role of recoil energy in the radiotoxicity of internal alpha-particle emitters. Radiat Res (1994) 0.87
Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells. Radiat Res (1994) 0.87
Testicular and plasma ascorbic acid levels in mice following dietary intake: a high-performance liquid chromatographic analysis. J Chromatogr (1993) 0.86
In vivo effects of iron-55 and iron-59 on mouse testes: biophysical dosimetry of Auger electrons. J Nucl Med (1985) 0.86
Ear pathology: its role in hearing impairment. J Soc Occup Med (1975) 0.86
Third-order optical nonlinearities of metallotetrabenzoporphyrins and a platinum poly-yne. Opt Lett (1992) 0.86
On the equivalent dose for Auger electron emitters. Radiat Res (1993) 0.86
Comparisons of point and average organ dose within an anthropomorphic physical phantom and a computational model of the newborn patient. Med Phys (2002) 0.86
Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothiouronium bromide hydrobromide (AET). J Nucl Med (1995) 0.85